Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred E Bertrand

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Cell Cycle (Georgetown, Tex.)|May 27, 2005
Conditional EGFR promotes cell cycle progression and prevention of apoptosis in the absence of autocrine cytokinesJohn G Shelton, Linda S Steelman, Steven L Abrams, et al.
Advances in Enzyme Regulation|July 21, 2006
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistanceJames A McCubrey, Linda S Steelman, Steven L Abrams, et al.
Oncotarget|June 17, 2014
GSK-3 as potential target for therapeutic intervention in cancerJames A McCubrey, Linda S Steelman, Fred E Bertrand, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Cell Cycle (Georgetown, Tex.)|May 27, 2005
Conditional EGFR promotes cell cycle progression and prevention of apoptosis in the absence of autocrine cytokinesJohn G Shelton, Linda S Steelman, Steven L Abrams, et al.
Advances in Enzyme Regulation|July 21, 2006
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistanceJames A McCubrey, Linda S Steelman, Steven L Abrams, et al.
Oncotarget|June 17, 2014
GSK-3 as potential target for therapeutic intervention in cancerJames A McCubrey, Linda S Steelman, Fred E Bertrand, et al.
Pageof 3